Roth Alexis M, Van Der Pol Barbara, Fortenberry J Dennis, Dodge Brian, Reece Michael, Certo David, Zimet Gregory D
a School of Public Health , Drexel University , Philadelphia , Pennsylvania , USA.
J Health Commun. 2015;20(2):230-6. doi: 10.1080/10810730.2014.920062. Epub 2014 Dec 12.
Epidemiologic data demonstrate that women involved with the criminal justice system in the United States are at high risk for sexually transmitted infections, including herpes simplex virus type 2 (HSV-2). Female defendants were recruited from a misdemeanor court to assess whether brief framed messages utilizing prospect theory could encourage testing for HSV-2. Participants were randomly assigned to a message condition (gain, loss, or control), completed an interviewer-administered survey assessing factors associated with antibody test uptake/refusal and were offered free point-of-care HSV-2 serologic testing. Although individuals in the loss-frame group accepted testing at the highest rate, an overall statistical difference in HSV-2 testing behavior by group (p ≤ .43) was not detected. The majority of the sample (74.6%) characterized receiving a serological test for HSV-2 as health affirming. However, this did not moderate the effect of the intervention nor was it significantly associated with test acceptance (p ≤ .82). Although the effects of message framing are subtle, the findings have important theoretical implications given the participants' characterization of HSV-2 screening as health affirming despite being a detection behavior. Implications of study results for health care providers interested in brief, low cost interventions are also explored.
流行病学数据表明,美国参与刑事司法系统的女性感染性传播感染的风险很高,包括2型单纯疱疹病毒(HSV-2)。从一个轻罪法庭招募女性被告,以评估运用前景理论的简短框架信息是否能鼓励进行HSV-2检测。参与者被随机分配到一个信息条件组(获益、损失或对照组),完成由访谈者进行的调查,评估与抗体检测接受/拒绝相关的因素,并获得免费的即时HSV-2血清学检测。虽然损失框架组的个体接受检测的比例最高,但未检测到各小组在HSV-2检测行为上的总体统计学差异(p≤0.43)。大多数样本(74.6%)将接受HSV-2血清学检测描述为对健康有益。然而,这并没有缓和干预的效果,也与检测接受情况没有显著关联(p≤0.82)。尽管信息框架的影响很微妙,但鉴于参与者将HSV-2筛查描述为对健康有益,尽管它是一种检测行为,这些发现具有重要的理论意义。还探讨了研究结果对有兴趣进行简短、低成本干预的医疗保健提供者的启示。